Toggle navigation
Home
Search
Services
Blog
Contact
About
Transcription Factors Mediating Opioid Plasticity
Comb, Michael J.
New England Biolabs, Inc., Ipswich, MA, United States
Search 24 grants from Michael Comb
Search grants from New England Biolabs, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulation of insulin signaling and sensitivity by the xenobiotic metabolizing enzyme NQO1
The Floral Dimension of African Malaria
Role of ETS-2 and SOD-1 in Down Syndrome Neuropathology
IRPG5 R01:Novel Phenotypes for Genetics of Alcoholism
Breast Cancer Education in North Manhattan
Recently added grants:
Multilevel factors for racial/ethnic and socioeconomic disparities in prognosis of hepatocellular carcinoma
Molecular and Circuit Mechanisms of Neurexin1-Mediated Goal-Directed Dysfunction
Examining binge eating in daily life: Working toward reducing obesity disparities in racially diverse lesbian and heterosexual women
Acquisition and Consolidation of Contextual Fear Memory in Engram Cell Pathways
Vasomotor and Sudomotor Activity During Heat Stress in Spinal Cord Injury
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
7R01DA005706-07
Application #
2118163
Study Section
Special Emphasis Panel (SRCD (03))
Project Start
1989-03-01
Project End
1996-02-29
Budget Start
1994-10-15
Budget End
1995-02-28
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
New England Biolabs, Inc.
Department
Type
DUNS #
066605403
City
Ipswich
State
MA
Country
United States
Zip Code
01938
Related projects
Publications
Comb, M; Goodman, H M
(1990)
CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2.
Nucleic Acids Res 18:3975-82
Comments
Be the first to comment on Michael Comb's grant